Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Efficacy and Safety of Injectable Platelet-Rich Fibrin Versus Intradermal Tranexamic Acid in the Treatment of Melasma: A Randomized Split-Face Study

NCT07540702 is registered in ClinicalTrials.gov with Kasr El Aini Hospital as lead sponsor.

NCT NCT07540702
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07540702 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Efficacy and Safety of Injectable Platelet-Rich Fibrin Versus Intradermal Tranexamic Acid in the Treatment of Melasma: A Randomized Split-Face Study
Lead sponsor
Kasr El Aini Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
February 1, 2026
Completion date
October 1, 2026
Enrollment
21 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

facial melasma, melasma